Stay updated on Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page.

Latest updates to the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.5.5 has been added, replacing the previous v3.5.4 entry. This reflects a new page revision being published.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedPage revision updated from v3.5.3 to v3.5.4, indicating deployment of a newer page version. This is an administrative update and does not modify study content or results.SummaryDifference0.0%

- Check29 days agoChange DetectedThe Taiwan site entry is updated from Taoyuan, Taiwan, 33305 to Taoyuan City, Taiwan, 33305. This clarifies the exact city designation for the site and helps participants locate the correct venue.SummaryDifference0.0%

- Check37 days agoChange DetectedEnrollment count was updated to 227. April 2026 timestamps were added to reflect the latest update, QC submission, and verification, replacing the earlier January values.SummaryDifference0.2%

- Check43 days agoChange DetectedThe page’s revision/version label has been updated from v3.5.2 to v3.5.3, indicating a site release rather than a substantive change to the study information.SummaryDifference0.0%

- Check51 days agoChange Detected- Revision: v3.5.2 is now shown, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page.